Our Board of Directors

Mary Jane Dykeman is a partner at INQ Law. Her data practice focuses on privacy, artificial intelligence (AI), and data strategy/governance.  In health, Mary Jane focuses on clinical and enterprise risk, privacy and information management, governance, corporate/commercial and more. She is COO to Woodway Assurance, a startup focused on automated risk assessment for de-identified data. She has held numerous leadership roles across Toronto teaching hospitals, most recently in a VP Legal & Risk role, and was instrumental in the development of Ontario’s health privacy legislation.

Mary Jane regularly consults on large data initiatives and use of data for health system planning, health research, quality purposes and advanced analytics. She is on the Advisory Council of Sweden’s Wilhelm Foundation in support of the Undiagnosed Hackathon, is Deputy Chair of the Canadian Blood Services Research Ethics Board; was on the inaugural data governance and advisory committees of the Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM); and is past chair, Alzheimer Society of Toronto.

Dr. Sadikovic holds the prestigious position of London Health Sciences Research Chair in Clinical Genomics and Epigenomics and is a Professor in the Department of Pathology and Laboratory Medicine, as well as the Department of Pediatrics at Western University. He is also the Scientific and Clinical Director of the Verspeeten Clinical Genome Centre at London Health Sciences, where he spearheads both clinical and translational genomics research focused on the development of genomic and epigenomic biomarkers and diagnostic technologies for rare, complex, and oncological disorders. In his clinical capacity, Dr. Sadikovic serves as the Program Head of the Molecular Diagnostics Program, overseeing the clinical molecular diagnostics laboratories at the London Health Sciences Centre. He completed his PhD at Western University, followed by a Canadian Cancer Society Postdoctoral Fellowship at Princess Margaret and SickKids Hospitals. His clinical training includes ABMG Clinical Molecular Genetics and Clinical Cytogenetics Fellowships at Baylor College of Medicine. Dr. Sadikovic is the inventor of the EpiSign technology and a leading principal investigator in numerous national and international studies focusing on the development and application of epigenomic biomarkers in rare diseases and other medical areas.

Josh Clark , CA CPA, is a seasoned finance professional with over 20+ years of experience, currently serving at London Health Sciences, one of Canada’s largest teaching hospitals. As a Chartered Professional Accountant, Josh has built a career focused on strategic planning, treasury management, capital allocation, and operational excellence. He is passionate about aligning financial strategy with organizational goals to drive sustainable growth and performance.

In addition to his professional role, Josh currently serves as the Chair of the Finance and Audit Committee and Board member at the London Community Foundation, where he supports initiatives that strengthen the local community.